Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Chunsheng Li, Ann-Marie Chacko, Jia Hu, Kosei Hasegawa, Jennifer Swails, Luigi Grasso, Wafik S El-Deiry, Nicholas Nicolaides, Vladimir R Muzykantov, Chaitanya R Divgi & George Coukos. (2014) Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model. Cancer Biology & Therapy 15:4, pages 443-451.
Read now
Read now
Joshua C Curtin. (2013) Novel drug discovery opportunities for colorectal cancer. Expert Opinion on Drug Discovery 8:9, pages 1153-1164.
Read now
Read now
Articles from other publishers (22)
Licheng Yao, Wenqing Cai, Shanmei Chen, Aidan Wang, Xin Wang, Chuanke Zhao, Chengchao Shou & Yanxing Jia. (2023) Design, syntheses and biological evaluation of natural product aiphanol derivatives and analogues: discovery of potent anticancer agents. Bioorganic & Medicinal Chemistry Letters, pages 129326.
Crossref
Crossref
Duarte Mendes Oliveira, Katia Grillone, Chiara Mignogna, Valentina De Falco, Carmelo Laudanna, Flavia Biamonte, Rosa Locane, Francesco Corcione, Massimiliano Fabozzi, Rosario Sacco, Giuseppe Viglietto, Donatella Malanga & Antonia Rizzuto. (2018) Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto-oncogene. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref
Dinesh Kumar Chellappan, Kun Hooi Leng, Lee Jia Jia, Nur Amirah Binti Abdul Aziz, Wong Chun Hoong, Yap Cheng Qian, Fam Yi Ling, Gwee Sing Wei, Tiong Ying, Jestin Chellian, Gaurav Gupta & Kamal Dua. (2018) The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: A review. Biomedicine & Pharmacotherapy 102, pages 1127-1144.
Crossref
Crossref
Angela Rynne-Vidal, José Jiménez-Heffernan, Concepción Fernández-Chacón, Manuel López-Cabrera & Pilar Sandoval. (2015) The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis. Cancers 7:4, pages 1994-2011.
Crossref
Crossref
Araceli Valverde, Jon Peñarando, Amanda Cañas, Laura M. López-Sánchez, Francisco Conde, Vanessa Hernández, Esther Peralbo, Chary López-Pedrera, Juan de la Haba-Rodríguez, Enrique Aranda & Antonio Rodríguez-Ariza. (2015) Simultaneous Inhibition of EGFR/VEGFR and Cyclooxygenase-2 Targets Stemness-Related Pathways in Colorectal Cancer Cells. PLOS ONE 10:6, pages e0131363.
Crossref
Crossref
Klaus Mross, Martin Büchert, Annette Frost, Michael Medinger, Peter Stopfer, Matus Studeny & Rolf Kaiser. (2014) Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis. BMC Cancer 14:1.
Crossref
Crossref
Armin Wiegering, Doreen Korb, Andreas Thalheimer, Ulrike Kämmerer, Jan Allmanritter, Niels Matthes, Michael Linnebacher, Nicolas Schlegel, Ingo Klein, Süleyman Ergün, Christoph-Thomas Germer & Christoph Otto. (2014) E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts. Neoplasia 16:11, pages 972-981.
Crossref
Crossref
Kelong Han, Jin Jin, Mauricio Maia, John Lowe, Martina A. Sersch & David E. Allison. (2014) Lower Exposure and Faster Clearance of Bevacizumab in Gastric Cancer and the Impact of Patient Variables: Analysis of Individual Data from AVAGAST Phase III Trial. The AAPS Journal 16:5, pages 1056-1063.
Crossref
Crossref
Chunsheng Li, Junying Wang, Jia Hu, Yi Feng, Kosei Hasegawa, Xiaohui Peng, Xingmei Duan, Aizhi Zhao, John L. Mikitsh, Vladimir R. Muzykantov, Ann-Marie Chacko, Daniel A. Pryma, Steven M. Dunn & George Coukos. (2014) Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer. Oncotarget 5:16, pages 6994-7012.
Crossref
Crossref
Thomas P?schinger, Anja Renner, Fabian Eisa, Michael Dobosz, Steffen Strobel, Thomas G. Weber, Robert Brauweiler, Willi A. Kalender & Werner Scheuer. (2014) Dynamic Contrast-Enhanced Micro?Computed Tomography Correlates With 3-Dimensional Fluorescence Ultramicroscopy in Antiangiogenic Therapy of Breast Cancer Xenografts. Investigative Radiology 49:7, pages 445-456.
Crossref
Crossref
Lotfi Abou-Elkacem, Susanne Arns, Gunnar Brix, Felix Gremse, Dieter Zopf, Fabian Kiessling & Wiltrud Lederle. (2013) Regorafenib Inhibits Growth, Angiogenesis, and Metastasis in a Highly Aggressive, Orthotopic Colon Cancer Model. Molecular Cancer Therapeutics 12:7, pages 1322-1331.
Crossref
Crossref
Helena Wållberg & Stefan Ståhl. (2013) Design and evaluation of radiolabeled tracers for tumor imaging. Biotechnology and Applied Biochemistry 60:4, pages 365-383.
Crossref
Crossref
Takuro Noguchi, Gerd Ritter & Hiroyoshi Nishikawa. (2013) Antibody-based therapy in colorectal cancer. Immunotherapy 5:5, pages 533-545.
Crossref
Crossref
Snezana Djordjevic & Paul C. Driscoll. (2013) Targeting VEGF signalling via the neuropilin co-receptor. Drug Discovery Today 18:9-10, pages 447-455.
Crossref
Crossref
Jing Li, Manish Gupta, Denise Jin, Yan Xin, Jennifer Visich & David E. Allison. (2012) Characterization of the long-term pharmacokinetics of bevacizumab following last dose in patients with resected stage II and III carcinoma of the colon. Cancer Chemotherapy and Pharmacology 71:3, pages 575-580.
Crossref
Crossref
Saeb Ahmad AshrafiSeyed Jalal HosseinimehrKambiz VarmiraSeyed Mohammad Abedi. (2012)
Radioimmunotherapy with
131
I-Bevacizumab as a Specific Molecule for Cells with Overexpression of the Vascular Endothelial Growth Factor
. Cancer Biotherapy and Radiopharmaceuticals 27:7, pages 420-425.
Crossref
Crossref
S De Bruyne, N Van Damme, P Smeets, L Ferdinande, W Ceelen, J Mertens, C Van de Wiele, R Troisi, L Libbrecht, S Laurent, K Geboes & M Peeters. (2012) Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases. British Journal of Cancer 106:12, pages 1926-1933.
Crossref
Crossref
Gagan Deep, Subhash Chander Gangar, Subapriya Rajamanickam, Komal Raina, Mallikarjuna Gu, Chapla Agarwal, Nicholas H. Oberlies & Rajesh Agarwal. (2012) Angiopreventive Efficacy of Pure Flavonolignans from Milk Thistle Extract against Prostate Cancer: Targeting VEGF-VEGFR Signaling. PLoS ONE 7:4, pages e34630.
Crossref
Crossref
C. Parisi, A. Markou & E.S. Lianidou. (2012) Development of a multiplexed PCR-coupled liquid bead array assay for vascular endothelial growth factor (VEGF) splice variants. Clinical Biochemistry 45:6, pages 475-482.
Crossref
Crossref
Philip Wei?hardt, Tanja Trarbach, Jan D?rig, Andreas Paul, Henning Reis, Derya Tilki, Inna Miroschnik, S?leyman Erg?n & Diana Klein. (2011) Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab. Histochemistry and Cell Biology 137:3, pages 391-401.
Crossref
Crossref
Laetitia Dahan, Joseph Ciccolini, Alexandre Evrard, Litaty Mbatchi, Jack Tibbitts, Pauline Ries, Emmanuelle Norguet, Cedric Mercier, Athanassios Iliadis, L'Houcine Ouafik, Bruno Lacarelle & Jean-Francois Seitz. (2012) Sudden Death Related to Toxicity in a Patient on Capecitabine and Irinotecan Plus Bevacizumab Intake: Pharmacogenetic Implications. Journal of Clinical Oncology 30:4, pages e41-e44.
Crossref
Crossref
Molly L. Flexman, Fotios Vlachos, Hyun Keol Kim, Shashank R. Sirsi, Jianzhong Huang, Sonia L. Hernandez, Tessa B. Johung, Jeffrey W. Gander, Ari R. Reichstein, Brooke S. Lampl, Antai Wang, Mark A. Borden, Darrell J. Yamashiro, Jessica J. Kandel & Andreas H. Hielscher. (2012) Monitoring early tumor response to drug therapy with diffuse optical tomography. Journal of Biomedical Optics 17:1, pages 016014.
Crossref
Crossref